Stock listing
NYSE American:TOVX Theriva Biologics, Inc. Stock
Home listing (NYSE American) of Theriva Biologics, Inc.
Follow Theriva Biologics, Inc. into a list and get an email when it puts out news.
Share price · AMEX:TOVX
$0.167 USD -0.002 (-1.1%)
Close on Nov 6, 2026
- Day range
- $0.160 – $0.173 USDNov 6, 2026
- Volume
- 407,486 sharesNov 6, 2026
- Market cap
- $7.64M USDAt the close on Nov 6, 2026 · price × 45.89M shares outstanding
- 52-week range
- $0.136 – $0.492 USDLowest and highest trades, Nov 7, 2025 – Nov 6, 2026
- Traded on an average day
- $376,783 USDMedian day 441,226 shares · last 3 months, Aug 6, 2026 – Nov 6, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NYSE American:TOVX · Home | $0.167 USD | -0.002 (-1.1%) | 407,486 | $0.166 | $0.173 | $0.160 | $0.168 | Close on Nov 6, 2026 |
Daily closes
Last 3 months, Aug 6, 2026 – Nov 6, 2026 · AMEX:TOVX · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.167 | -0.002 | -1.1% | $0.166 | $0.173 | $0.160 | 407,486 | |
| $0.168 | -0.022 | -11.4% | $0.186 | $0.188 | $0.136 | 1,454,838 | |
| $0.190 | +0.008 | +4.4% | $0.179 | $0.199 | $0.176 | 1,077,225 | |
| $0.182 | -0.002 | -1.1% | $0.185 | $0.202 | $0.178 | 2,338,997 | |
| $0.184 | +0.013 | +7.9% | $0.150 | $0.191 | $0.136 | 90,789,704 | |
| $0.171 | -0.016 | -8.8% | $0.187 | $0.188 | $0.167 | 1,431,716 | |
| $0.187 | -0.003 | -1.5% | $0.187 | $0.190 | $0.185 | 444,054 | |
| $0.190 | +0.002 | +1.0% | $0.187 | $0.191 | $0.184 | 229,027 | |
| $0.188 | -0.005 | -2.8% | $0.193 | $0.195 | $0.184 | 546,555 | |
| $0.193 | -0.003 | -1.3% | $0.191 | $0.196 | $0.190 | 410,266 | |
| $0.196 | +0.006 | +3.2% | $0.190 | $0.200 | $0.190 | 429,863 | |
| $0.190 | -0.007 | -3.4% | $0.200 | $0.204 | $0.190 | 589,099 | |
| $0.197 | -0.011 | -5.5% | $0.210 | $0.217 | $0.197 | 751,284 | |
| $0.208 | +0.003 | +1.6% | $0.209 | $0.214 | $0.204 | 331,501 | |
| $0.205 | -0.003 | -1.5% | $0.208 | $0.210 | $0.205 | 237,302 | |
| $0.208 | -0.004 | -1.9% | $0.217 | $0.217 | $0.208 | 251,002 | |
| $0.212 | +0.002 | +1.0% | $0.211 | $0.221 | $0.210 | 364,404 | |
| $0.210 | -0.006 | -2.7% | $0.216 | $0.223 | $0.210 | 381,994 | |
| $0.216 | -0.004 | -1.7% | $0.224 | $0.225 | $0.215 | 360,156 | |
| $0.219 | +0.002 | +1.1% | $0.220 | $0.236 | $0.210 | 1,621,073 | |
| $0.217 | -0.010 | -4.4% | $0.226 | $0.233 | $0.212 | 488,335 | |
| $0.227 | -0.007 | -2.9% | $0.234 | $0.237 | $0.227 | 526,775 | |
| $0.234 | +0.012 | +5.4% | $0.227 | $0.247 | $0.224 | 808,288 | |
| $0.222 | -0.003 | -1.3% | $0.226 | $0.237 | $0.220 | 407,433 | |
| $0.225 | 0.000 | 0.0% | $0.229 | $0.238 | $0.225 | 382,929 | |
| $0.225 | +0.000 | 0.0% | $0.230 | $0.239 | $0.225 | 399,098 | |
| $0.225 | 0.000 | 0.0% | $0.227 | $0.233 | $0.221 | 427,022 | |
| $0.225 | +0.015 | +7.1% | $0.223 | $0.233 | $0.220 | 856,012 | |
| $0.210 | -0.007 | -3.0% | $0.219 | $0.220 | $0.210 | 462,731 | |
| $0.217 | -0.004 | -1.9% | $0.226 | $0.228 | $0.213 | 759,345 | |
| $0.221 | -0.010 | -4.3% | $0.220 | $0.235 | $0.220 | 338,137 | |
| $0.231 | -0.004 | -1.8% | $0.232 | $0.236 | $0.230 | 312,746 | |
| $0.235 | +0.004 | +1.7% | $0.234 | $0.239 | $0.231 | 327,782 | |
| $0.231 | 0.000 | 0.0% | $0.230 | $0.239 | $0.230 | 235,790 | |
| $0.231 | -0.003 | -1.2% | $0.235 | $0.239 | $0.226 | 321,463 | |
| $0.234 | -0.008 | -3.5% | $0.241 | $0.245 | $0.232 | 198,588 | |
| $0.242 | +0.016 | +7.1% | $0.235 | $0.245 | $0.230 | 547,043 | |
| $0.226 | +0.001 | +0.4% | $0.230 | $0.232 | $0.225 | 472,309 | |
| $0.225 | -0.011 | -4.5% | $0.237 | $0.240 | $0.220 | 548,440 | |
| $0.236 | -0.012 | -4.8% | $0.243 | $0.243 | $0.236 | 779,833 | |
| $0.248 | +0.005 | +2.0% | $0.246 | $0.248 | $0.241 | 344,417 | |
| $0.243 | -0.006 | -2.5% | $0.245 | $0.249 | $0.243 | 357,980 | |
| $0.249 | +0.002 | +0.8% | $0.251 | $0.251 | $0.241 | 415,953 | |
| $0.247 | -0.006 | -2.3% | $0.246 | $0.253 | $0.246 | 377,579 | |
| $0.253 | 0.000 | 0.0% | $0.260 | $0.260 | $0.248 | 431,523 | |
| $0.253 | +0.005 | +2.0% | $0.251 | $0.261 | $0.243 | 889,260 | |
| $0.248 | -0.001 | -0.4% | $0.248 | $0.257 | $0.245 | 419,298 | |
| $0.249 | -0.001 | -0.4% | $0.257 | $0.258 | $0.240 | 516,312 | |
| $0.250 | +0.005 | +2.0% | $0.243 | $0.259 | $0.243 | 300,129 | |
| $0.245 | -0.007 | -2.9% | $0.252 | $0.261 | $0.243 | 564,410 | |
| $0.253 | +0.009 | +3.8% | $0.243 | $0.262 | $0.235 | 1,544,487 | |
| $0.243 | +0.006 | +2.4% | $0.239 | $0.245 | $0.236 | 438,397 | |
| $0.238 | +0.002 | +1.0% | $0.245 | $0.245 | $0.238 | 378,525 | |
| $0.235 | +0.000 | 0.0% | $0.236 | $0.242 | $0.233 | 365,720 | |
| $0.235 | +0.005 | +2.1% | $0.237 | $0.245 | $0.231 | 521,670 | |
| $0.230 | +0.005 | +2.1% | $0.232 | $0.238 | $0.227 | 413,282 | |
| $0.225 | 0.000 | 0.0% | $0.224 | $0.236 | $0.224 | 807,526 | |
| $0.226 | -0.012 | -5.1% | $0.235 | $0.235 | $0.224 | 463,287 | |
| $0.238 | +0.010 | +4.2% | $0.236 | $0.240 | $0.223 | 556,529 | |
| $0.228 | -0.002 | -0.9% | $0.235 | $0.238 | $0.220 | 560,028 | |
| $0.230 | -0.010 | -4.2% | $0.243 | $0.254 | $0.230 | 922,875 | |
| $0.240 | +0.010 | +4.3% | $0.228 | $0.240 | $0.228 | 895,105 | |
| $0.230 | -0.001 | -0.4% | $0.224 | $0.236 | $0.223 | 417,537 | |
| $0.231 | +0.010 | +4.6% | $0.224 | $0.234 | $0.220 | 471,853 | |
| $0.221 | -0.004 | -1.8% | $0.226 | $0.231 | $0.220 | 305,810 | |
| $0.225 | 0.000 | -0.1% | $0.227 | $0.232 | $0.220 | 446,213 |
- Ticker
- NYSE American:TOVX
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NYSE American
- Currency
- USD
What changed lately
Latest news release · Nov 2, 2026
Theriva™ Biologics Announces Sale of SYN-004 (ribaxamase) and Related Antibiotic-Degrading Enzyme Portfolio to Biossil Labs Inc.
Latest deck · May 2026
Investor Presentation (May 2026)
Investor deck · 53 slides
Calls
Replays
Theriva Biologics (NYSE American: TOVX) Q4 2023 Earnings Call
Mon, Mar 25, 2024 · 8:30 AM ET
Watch TranscriptTheriva Biologics (NYSE American: TOVX) Q3 2023 Earnings Call
Mon, Nov 13, 2023 · 8:30 AM ET
Watch TranscriptTheriva Biologics (NYSE American: TOVX) Q2 2023 Earnings Call
Tue, Aug 08, 2023 · 8:30 AM ET
Watch Transcript
Latest news
Theriva™ Biologics Announces Sale of SYN-004 (ribaxamase) and Related Antibiotic-Degrading Enzyme Portfolio to Biossil Labs Inc.
Nov 2, 2026
Closed $0.184 (+7.9%) on Nov 2, 2026
Theriva Biologics Reports Second Quarter 2026 Operational Highlights and Financial Results
Aug 12, 2026
Closed $0.24 (+4.3%) on Aug 12, 2026
Theriva Biologics: Q2 Earnings Snapshot
Aug 11, 2026
Closed $0.23 (-0.4%) on Aug 11, 2026
Theriva Biologics Announces First Patient Dosed in VIRAGE2 Phase 2a Clinical Trial to Evaluate More Frequent Dosing of VCN-01 in First-Line Patients with Metastatic Pancreatic Ductal Adenocarcinoma
Aug 7, 2026
Closed $0.221 (-1.8%) on Aug 7, 2026
Theriva™ Biologics Announces First Patient Dosed in VIRAGE2 Phase 2a Clinical Trial to Evaluate More Frequent Dosing of VCN-01 (zabilugene almadenorepvec) in First-Line Patients with Metastatic Pancreatic Ductal Adenocarcinoma
Aug 6, 2026
Closed $0.225 (-0.1%) on Aug 6, 2026
Theriva™ Biologics Reports First Quarter 2026 Operational Highlights and Financial Results
May 5, 2026
Closed $0.382 (+0.5%) on May 6, 2026
Theriva™ Biologics Announces Upcoming Presentation of Additional Data from the VIRAGE Phase 2b Clinical Trial of VCN-01 in Metastatic Pancreatic Cancer at AACR 2026 Annual Meeting
Apr 17, 2026
Closed $0.41 (+59.4%) on Apr 20, 2026
Theriva™ Biologics Announces Positive End-of-Phase 2 Meeting with U.S. FDA Regarding the Design of a Phase 3 Trial of VCN-01 in Metastatic Pancreatic Ductal Adenocarcinoma
Mar 23, 2026
Closed $0.21 (+8.4%) on Mar 23, 2026
Theriva™ Biologics Reports Full-Year 2025 Operational Highlights and Financial Results
Mar 12, 2026
Closed $0.181 (+1.2%) on Mar 12, 2026
Theriva™ Biologics Licenses SYN-020 to Rasayana Therapeutics for Multiple Indications
Feb 18, 2026
Closed $0.192 (+6.3%) on Feb 18, 2026
Financings
Warrant exercise of existing warrants exercised at reduced price, with new unregistered warrants
Oct 16, 2025
Announced: about US$4M · US$0.54 a share · Warrants at US$0.54 for 60 months · A.G.P./Alliance Global Partners
Dealers: A.G.P./Alliance Global Partners
Use of proceeds: Working capital and other general corporate purposes
Public offering of shares of common stock (or pre-funded warrants) and accompanying warrants
May 8, 2025
Closed: US$7.5M raised · US$1.1 a share · Warrants at US$1.1 for 60 months · A.G.P./Alliance Global Partners
Dealers: A.G.P./Alliance Global Partners (lead)
Use of proceeds: Working capital and general corporate purposes, including research and development and manufacturing scale-up
Decks
Investor Presentation (May 2026)
Investor deck · 53 slides · May 2026
Investor Presentation (January 2026)
Investor deck · 54 slides · January 2026
Technical Presentation (October 2025)
Technical · 15 slides · Oct 20, 2025
Technical Presentation (October 2025)
Technical · 33 slides · Oct 8, 2025
Theriva Biologics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 16 in the last 12 months · 27 in all · newest Nov 2, 2026 · oldest 2025
- Calls
- 6 calls with a replay · 6 with a transcript · latest Mar 25, 2024
- Decks
- 51 decks · latest May 2026
Where Theriva Biologics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NYSE American:TOVX · Home listing · This page | NYSE American | United States | USD |
| BOATS:TOVX | BOATS | United States | USD |
| Lang & Schwarz:A40MGC | Lang & Schwarz | Germany | EUR |
| gettex:SFY0 | gettex | Germany | EUR |
| Frankfurt:SFY0 | Frankfurt | Germany | EUR |
| Munich:SFY0 | Munich | Germany | EUR |
Log in to ask 6ix AI your own questions about Theriva Biologics, Inc.